ArticleInternal medicine (Tokyo, Japan)2020

Clinical Significance of Inotuzumab Ozogamicin in Non-transplant Patients with Relapsed Acute Lymphoblastic Leukemia: A Report of Four Cases.

Miyuki Okura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.